Intelligent Bio Solutions News

Intelligent Bio Solutions Reports Preliminary Unaudited Fiscal Q3 Results

Seeking AlphaApr 19 02:58

Intelligent Bio Solutions Sees Prelim. Q3 2024 Revenue $0.82M Vs $1.190M Est.

Intelligent Bio Solutions Sees Prelim. Q3 2024 Revenue $0.82M Vs $1.190M Est.

BenzingaApr 18 20:38

Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS

Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS

Dow JonesApr 18 20:34

Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results

Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprint

Intelligent Bio SolutionsApr 18 12:00

Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio With Grant of New European Patent With Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsApr 11 12:00

Looking Into Intelligent Bio Solutions's Recent Short Interest

Intelligent Bio Solutions's (NYSE:INBS) short percent of float has risen 57.64% since its last report. The company recently reported that it has 90 thousand shares sold short, which is 3.2% of all reg

BenzingaApr 6 00:45

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsMar 26 12:00

Intelligent Bio Solutions Inc Files For Offering Of Up To 6.8M Shares By The Selling Stockholders

Intelligent Bio Solutions Inc Files For Offering Of Up To 6.8M Shares By The Selling Stockholders

BenzingaMar 19 03:36

Press Release: Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("IN

Dow JonesMar 13 07:30

Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsMar 12 12:00

Press Release: Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the

Dow JonesMar 11 20:30

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsMar 11 12:00

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAinos (NASDAQ:AIMD) shares increased by 144.6% to $2.74 during Friday's pre-market session. The company's market cap stands at $12.8 million. Psyence Biomedical (NASDAQ:PBM) stock moved upwards

BenzingaMar 8 21:09

Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now

Yahoo FinanceMar 5 20:00

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsMar 1 13:00

Intelligent Bio Solutions Partners With Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsFeb 28 13:00

Peering Into Intelligent Bio Solutions's Recent Short Interest

Intelligent Bio Solutions's (NYSE:INBS) short percent of float has risen 165.35% since its last report. The company recently reported that it has 73 thousand shares sold short, which is 10.11% of all

BenzingaFeb 20 02:45

Intelligent Bio Solutions Inc. Regains Compliance With Nasdaq Minimum Bid Price Requirement and Confirms Compliance With Minimum Stockholders' Equity Requirement

NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing

Intelligent Bio SolutionsFeb 16 13:00

VUZI, TCBP and MANU Among Pre-market Losers

Seeking AlphaFeb 12 21:27

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersSeaStar Medical Holding (NASDAQ:ICU) shares rose 27.9% to $1.1 during Monday's pre-market session. The company's market cap stands at $71.6 million. Aesthetic Medical Intl (NASDAQ:AIH) shares i

BenzingaFeb 12 21:05